Standard BioTools Total Current Liabilities 2010-2025 | LAB
Standard BioTools total current liabilities from 2010 to 2025. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
| Standard BioTools Annual Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $66 |
| 2023 | $109 |
| 2022 | $43 |
| 2021 | $50 |
| 2020 | $54 |
| 2019 | $33 |
| 2018 | $38 |
| 2017 | $33 |
| 2016 | $30 |
| 2015 | $30 |
| 2014 | $29 |
| 2013 | $18 |
| 2012 | $12 |
| 2011 | $20 |
| 2010 | $19 |
| 2009 | $7 |
| Standard BioTools Quarterly Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2025-06-30 | $98 |
| 2025-03-31 | $56 |
| 2024-12-31 | $66 |
| 2024-09-30 | $121 |
| 2024-06-30 | $124 |
| 2024-03-31 | $122 |
| 2023-12-31 | $109 |
| 2023-09-30 | $52 |
| 2023-06-30 | $47 |
| 2023-03-31 | $44 |
| 2022-12-31 | $43 |
| 2022-09-30 | $46 |
| 2022-06-30 | $43 |
| 2022-03-31 | $47 |
| 2021-12-31 | $50 |
| 2021-09-30 | $47 |
| 2021-06-30 | $53 |
| 2021-03-31 | $54 |
| 2020-12-31 | $54 |
| 2020-09-30 | $43 |
| 2020-06-30 | $38 |
| 2020-03-31 | $35 |
| 2019-12-31 | $33 |
| 2019-09-30 | $33 |
| 2019-06-30 | $37 |
| 2019-03-31 | $34 |
| 2018-12-31 | $38 |
| 2018-09-30 | $39 |
| 2018-06-30 | $37 |
| 2018-03-31 | $34 |
| 2017-12-31 | $33 |
| 2017-09-30 | $32 |
| 2017-06-30 | $34 |
| 2017-03-31 | $31 |
| 2016-12-31 | $30 |
| 2016-09-30 | $28 |
| 2016-06-30 | $32 |
| 2016-03-31 | $31 |
| 2015-12-31 | $30 |
| 2015-09-30 | $27 |
| 2015-06-30 | $29 |
| 2015-03-31 | $25 |
| 2014-12-31 | $29 |
| 2014-09-30 | $27 |
| 2014-06-30 | $27 |
| 2014-03-31 | $26 |
| 2013-12-31 | $18 |
| 2013-09-30 | $15 |
| 2013-06-30 | $12 |
| 2013-03-31 | $12 |
| 2012-12-31 | $12 |
| 2012-09-30 | $13 |
| 2012-06-30 | $15 |
| 2012-03-31 | $18 |
| 2011-12-31 | $20 |
| 2011-09-30 | $20 |
| 2011-06-30 | $18 |
| 2011-03-31 | $19 |
| 2010-12-31 | $19 |
| 2010-09-30 | $11 |
| 2010-06-30 | |
| 2010-03-31 | |
| 2009-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.481B | $0.174B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.991B | 53.84 |
| Tempus AI (TEM) | United States | $13.179B | 0.00 |
| Doximity (DOCS) | United States | $12.725B | 56.62 |
| Hims & Hers Health (HIMS) | United States | $9.572B | 78.43 |
| IRhythm Technologies (IRTC) | United States | $5.461B | 0.00 |
| Hinge Health (HNGE) | United States | $4.399B | 0.00 |
| Privia Health (PRVA) | United States | $2.828B | 209.45 |
| Inspire Medical Systems (INSP) | United States | $2.771B | 40.73 |
| Heartflow (HTFL) | $2.557B | 0.00 | |
| Phreesia (PHR) | United States | $1.884B | 0.00 |
| Enovis (ENOV) | United States | $1.766B | 9.34 |
| 10x Genomics (TXG) | United States | $1.744B | 0.00 |
| Omnicell (OMCL) | United States | $1.497B | 28.84 |
| Schrodinger (SDGR) | United States | $1.436B | 0.00 |
| Azenta (AZTA) | United States | $1.400B | 61.08 |
| Clover Health Investments (CLOV) | United States | $1.343B | 0.00 |
| Claritev (CTEV) | United States | $1.135B | 0.00 |
| Evolent Health (EVH) | United States | $1.134B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.679B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.652B | 0.00 |
| Veradigm (MDRX) | United States | $0.531B | 0.00 |
| Talkspace (TALK) | United States | $0.445B | 133.00 |
| Butterfly Network (BFLY) | United States | $0.405B | 0.00 |
| Carlsmed (CARL) | United States | $0.353B | 0.00 |
| TruBridge (TBRG) | United States | $0.300B | 52.53 |
| Outset Medical (OM) | United States | $0.247B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.239B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.234B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.213B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.195B | 0.00 |
| CapsoVision (CV) | United States | $0.175B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.168B | 0.00 |
| CareCloud (CCLD) | United States | $0.163B | 7.38 |
| American Well (AMWL) | United States | $0.111B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.109B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.077B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.072B | 0.00 |
| Pulmonx (LUNG) | United States | $0.070B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| 111 (YI) | China | $0.056B | 0.00 |
| HeartBeam (BEAT) | United States | $0.046B | 0.00 |
| Zhongchao (ZCMD) | China | $0.025B | 0.00 |
| Precipio (PRPO) | United States | $0.025B | 0.00 |
| PROFUSA (PFSA) | United States | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.013B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |